U.S. Approves Lilly's Cymbalta for Fibromyalgia
From Reuters Health - Jun 16, 2008
NEW YORK (Reuters) - Eli Lilly and Co said Monday its antidepressant
Cymbalta won U.S. approval for addressing the pain condition
fibromyalgia, opening up a new market that could propel the drug's
sales. Pharmaceutical companies have been racing to bring drugs to
market for fibromyalgia, a sometimes debilitating disorder that affects
mostly women. Cymbalta's approval follows clearance in fibromyalgia for
Pfizer's Lyrica.
www.peoplewho.org